AllianceBernstein’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $297K | Hold |
5,300
| – | – | ﹤0.01% | 2886 |
|
|
2025
Q4 | $297K | Hold |
5,300
| – | – | ﹤0.01% | 2910 |
|
|
2025
Q3 | $334K | Hold |
5,300
| – | – | ﹤0.01% | 2895 |
|
|
2025
Q2 | $302K | Buy |
5,300
+200
| +4% | +$10.9K | ﹤0.01% | 2910 |
|
|
2025
Q1 | $286K | Hold |
5,100
| – | – | ﹤0.01% | 2795 |
|
|
2024
Q4 | $313K | Hold |
5,100
| – | – | ﹤0.01% | 2845 |
|
|
2024
Q3 | $341K | Hold |
5,100
| – | – | ﹤0.01% | 2851 |
|
|
2024
Q2 | $341K | Buy |
5,100
+300
| +6% | +$20.4K | ﹤0.01% | 2863 |
|
|
2024
Q1 | $341K | Hold |
4,800
| – | – | ﹤0.01% | 2759 |
|
|
2023
Q4 | $404K | Hold |
4,800
| – | – | ﹤0.01% | 2713 |
|
|
2023
Q3 | $413K | Hold |
4,800
| – | – | ﹤0.01% | 2667 |
|
|
2023
Q2 | $447K | Buy |
4,800
+100
| +2% | +$9.42K | ﹤0.01% | 2695 |
|
|
2023
Q1 | $445K | Hold |
4,700
| – | – | ﹤0.01% | 2619 |
|
|
2022
Q4 | $472K | Buy |
4,700
+100
| +2% | +$9.13K | ﹤0.01% | 2660 |
|
|
2022
Q3 | $392K | Sell |
4,600
-100
| -2% | -$8.83K | ﹤0.01% | 2752 |
|
|
2022
Q2 | $404K | Hold |
4,700
| – | – | ﹤0.01% | 2770 |
|
|
2022
Q1 | $422K | Hold |
4,700
| – | – | ﹤0.01% | 2746 |
|
|
2021
Q4 | $470K | Hold |
4,700
| – | – | ﹤0.01% | 2773 |
|
|
2021
Q3 | $436K | Hold |
4,700
| – | – | ﹤0.01% | 2804 |
|
|
2021
Q2 | $400K | Buy |
4,700
+200
| +4% | +$17.3K | ﹤0.01% | 2905 |
|
|
2021
Q1 | $390K | Hold |
4,500
| – | – | ﹤0.01% | 2785 |
|
|
2020
Q4 | $379K | Hold |
4,500
| – | – | ﹤0.01% | 2734 |
|
|
2020
Q3 | $359K | Sell |
4,500
-300
| -6% | -$24.9K | ﹤0.01% | 2716 |
|
|
2020
Q2 | $425K | Buy |
4,800
+300
| +7% | +$26.9K | ﹤0.01% | 2714 |
|
|
2020
Q1 | $423K | Buy |
4,500
+300
| +7% | +$27.9K | ﹤0.01% | 2434 |
|
|
2019
Q4 | $453K | Hold |
4,200
| – | – | ﹤0.01% | 2586 |
|
|
2019
Q3 | $403K | Buy |
4,200
+300
| +8% | +$27.9K | ﹤0.01% | 2663 |
|
|
2019
Q2 | $373K | Buy |
3,900
+100
| +3% | +$8.42K | ﹤0.01% | 2739 |
|
|
2019
Q1 | $335K | Buy |
3,800
+300
| +9% | +$26.4K | ﹤0.01% | 2706 |
|
|
2018
Q4 | $291K | Buy |
3,500
+100
| +3% | +$8.8K | ﹤0.01% | 2746 |
|
|
2018
Q3 | $320K | Buy |
3,400
+200
| +6% | +$19.1K | ﹤0.01% | 2816 |
|
|
2018
Q2 | $352K | Buy |
3,200
+600
| +23% | +$62.7K | ﹤0.01% | 2753 |
|
|
2018
Q1 | $257K | Buy |
+2,600
| New | +$232K | ﹤0.01% | 2753 |
|
|
2015
Q2 | – | Sell |
-100
| Closed | -$6K | – | 3261 |
|
|
2015
Q1 | $6K | Hold |
100
| – | – | ﹤0.01% | 3405 |
|
|
2014
Q4 | $6K | Hold |
100
| – | – | ﹤0.01% | 3355 |
|
|
2014
Q3 | $5K | Sell |
100
-100
| -50% | -$5.08K | ﹤0.01% | 3354 |
|
|
2014
Q2 | $10K | Buy |
+200
| New | +$10.3K | ﹤0.01% | 3312 |
|
|
2013
Q4 | – | Sell |
-200
| Closed | -$12K | – | 3480 |
|
|
2013
Q3 | $12K | Sell |
200
-82
| -29% | -$4.47K | ﹤0.01% | 3140 |
|
|
2013
Q2 | $15K | Buy |
+282
| New | +$13.3K | ﹤0.01% | 3095 |
|
Other funds holding UTMD
BIP
VCM
MA
RHJA
AllianceBernstein's UTMD Position: Q1 2026 in Review
AllianceBernstein held its Utah Medical Products (UTMD) position steady in Q1 2026 at 5,300 shares worth $297K. The position accounts for ﹤0.01% of the portfolio, ranked #2886.
AllianceBernstein first reported a position in UTMD in Q2 2013 and has held it in 39 quarters since. The position peaked at $472K in Q4 2022. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.
- AllianceBernstein held 5,300 shares of Utah Medical Products worth $297K as of Q1 2026.
- AllianceBernstein left its Utah Medical Products share count unchanged in Q1 2026.
- Utah Medical Products made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2886 holding.
- AllianceBernstein first reported a position in Utah Medical Products in Q2 2013 and has held it in 39 quarters since.
- AllianceBernstein's Utah Medical Products position peaked at $472K in Q4 2022.
- 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.
Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.